InvestorsHub Logo
Followers 27
Posts 2850
Boards Moderated 0
Alias Born 10/17/2009

Re: None

Wednesday, 11/21/2012 10:05:35 AM

Wednesday, November 21, 2012 10:05:35 AM

Post# of 125
Medgenics Granted U.S. Patent for Core Technology Used in Sustained Delivery of Erythropoietin, Aimed at Multi-Billion Dollar Anemia Market
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.